Hypoglycemic Agents/adverse effects

Doran, W. ., Tunnicliffe, L. ., Muzambi, R. ., Rentsch, C. T., Bhaskaran, K. ., Smeeth, L. ., … Warren-Gash, C. . (2024). Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records. BMJ Open Diabetes Res Care, 12. http://doi.org/10.1136/bmjdrc-2023-003548
Pradhan, R. ., Lu, S. ., Yin, H. ., H. Y. Yu, O. ., Ernst, P. ., Suissa, S. ., & Azoulay, L. . (2022). Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study. Bmj, 379, e071380. http://doi.org/10.1136/bmj-2022-071380